Studies have reported that CD4+ T cells inhibit tumor growth by secreting cytokines [33], and tumor-infiltrating CD4+ T cells are associated with increased overall survival of CCA patients [34]. The gene discussed is CD4; the disease is cholangiocarcinoma.